XXI Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
XXI Wealth's AZN Position: Q3 2026 in Review
XXI Wealth increased its AstraZeneca (AZN) stake by 22% in Q3 2026, buying an estimated $388K and bringing the position to 12,948 shares worth $2.09M. The position accounts for 0.84% of the portfolio, ranked #25.
XXI Wealth first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.22M in Q1 2026. 1,242 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- XXI Wealth held 12,948 shares of AstraZeneca worth $2.09M as of Q3 2026.
- XXI Wealth bought 2,329 AstraZeneca shares in Q3 2026, an estimated $388K.
- AstraZeneca made up 0.84% of XXI Wealth's portfolio in Q3 2026, its #25 holding.
- XXI Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
- XXI Wealth's AstraZeneca position peaked at $2.22M in Q1 2026.
- 1,242 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.